Wolverine Asset Management’s Aerie Pharmaceuticals AERI Stock Holding History

Wolverine Asset Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,000	Closed	-$14K	–	2658
2021 Q4	$14K	Hold	2,000	–	–	﹤0.01%	1803
2021 Q3	$22K	Buy	+2,000	New	+$29.2K	﹤0.01%	1614
2020 Q3	–	Sell	-15,600	Closed	-$230K	–	1852
2020 Q2	$230K	Sell	15,600 -2,500	-14%	-$37K	﹤0.01%	889
2020 Q1	$244K	Buy	18,100 +15,600	+624%	+$296K	﹤0.01%	847
2019 Q4	$60K	Buy	+2,500	New	+$51.8K	﹤0.01%	1169

Wolverine Asset Management's AERI Position: Q4 2022 in Review

Wolverine Asset Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 11,841 shares — an estimated $179K sold.

Wolverine Asset Management first reported a position in AERI in Q1 2020 and held it in 4 quarters. The position peaked at $179K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Wolverine Asset Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Wolverine Asset Management sold 11,841 Aerie Pharmaceuticals shares in Q4 2022, an estimated $179K.
Wolverine Asset Management first reported a position in Aerie Pharmaceuticals in Q1 2020 and held it in 4 quarters.
Wolverine Asset Management's Aerie Pharmaceuticals position peaked at $179K in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Wolverine Asset Management's 13F filing for Q4 2022, filed 1 Feb 2023.